AllianceRx Walgreens Prime Studies Adherence in Cystic Fibrosis, Ulcerative Colitis/Crohn ' s Disease Patients
ORLANDO, Fla., June 1, 2022. AllianceRx Walgreens Prime and Walgreens recently announced results from separate research studies exploring the impact of adherence on hospitalizations and medical costs as they related to cystic fibrosis (CF) and...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | Crohn's Disease | Cystic Fibrosis | Inflammatory Bowel Disease | Pharmaceuticals | Study | Ulcerative Colitis